Effects of Garcinia mangostana Peel Extract on Glycemic Control in Type 2 Diabetes Mellitus: A Systematic Review of Human Studies

A Systematic Review of Human Studies

Authors

  • Yosef Purwoko 1. Division of Geriatrics, Department of Internal Medicine, Diponegoro University, Semarang, Indonesia. 2. Doctor of Medical Science and Health Study Program, Faculty of Medicine, Diponegoro University, Semarang, Indonesia.
  • K Heri Nugroho Division of Endocrinology, Metabolism, and Diabetes, Department of Internal Medicine, Diponegoro University, Semarang, Indonesia
  • Siti Setiati Division of Geriatrics, Department of Internal Medicine, Universitas Indonesia, Jakarta, Indonesia
  • Banundari Rachmawati Department of Clinical Pathology, Diponegoro University, Semarang, Indonesia

Keywords:

Garcinia mangostana, mangosteen peel extract, α-mangostin, type 2 diabetes mellitus, insulin resistance, oxidative stress

Abstract

Introduction: Type 2 diabetes mellitus (T2DM) is a major global health concern characterized by insulin resistance, hyperglycemia, and chronic inflammation. Interest in natural adjunctive therapies has increased, particularly in mangosteen (Garcinia mangostana), which contains xanthone compounds in the peel with potential antidiabetic properties. Methods: This systematic review followed PRISMA 2020 guidelines. Literature searches were conducted using PubMed, Google Scholar, and ClinicalKey up to December 2022 for studies assessing mangosteen peel extract (MPE) or α-mangostin in diabetic human subjects. Eligible studies included randomized controlled and quasi-experimental trials reporting glycemic or metabolic outcomes. Risk of bias was evaluated using the Cochrane RoB tool. The primary result of this study is to evaluate the effects of mangosteen peel extract supplementation on key glycemic outcomes in patients with T2DM, specifically fasting blood glucose (FBG), HOMA-IR, and HbA1c. Results: A total of two studies (n=2) met the inclusion criteria. A randomized controlled pilot trial reported significant improvement in insulin sensitivity (HOMA-IR −53.2% vs −15.2%; p = 0.004) after 26 weeks of standardized mangosteen extract. A small quasi-experimental study reported a significant reduction in FBG following 7 days of mangosteen peel decoction. Discussion: Limited clinical evidence indicates that mangosteen peel extract may improve insulin sensitivity and lower fasting glucose in T2DM. However, the conclusions are limited by the small number of available studies, the short follow-up duration in one trial, and variability in extract preparation. Conclusion: Mangosteen peel extract demonstrates promising glycemic benefits, including improved insulin sensitivity and reduced fasting glucose. However, the available evidence remains limited by small sample sizes, short follow-up periods, and heterogeneity in extract formulations. Larger randomized controlled trials using standardized preparations are required before clinical recommendations can be made.

References

Watanabe M, Yamaoka-Tojo M, Sano S, Tojo T. Mangosteen extract shows a potent insulin-sensitizing effect in obese female patients: a prospective randomized controlled pilot study. Nutrients. 2018;10(5):586. doi:10.3390/nu10050586.

International Diabetes Federation. IDF diabetes atlas. 10th ed. 2021. Accessed 2023 Apr 24. Available from: https://diabetesatlas.org/.

Enikmawati A, Sholihah AM, Sarifah S. Pengaruh kulit manggis terhadap penurunan kadar gula darah pada penderita diabetes mellitus. Jurnal Rumpun Ilmu Kesehatan. 2022;2(2):90–4.

Patrick M, Zohdi WN, Abd Muid S, Omar E. Alpha (α)-mangostin (xanthone of Garcinia mangostana L.): augmenting macrophage activity for an effective diabetic wound healing. Trends in Sciences. 2024;21(10):8254.

Li J, Nie X, Rangsinth P, et al. Structure and activity relationship analysis of xanthones from mangosteen: identifying garcinone E as a potent dual EGFR and VEGFR2 inhibitor. Phytomedicine. 2024;122:155140.

Ansori AN, Antonius Y, Murtadlo AA, et al. Natural products isolated from various parts of mangosteen (Garcinia mangostana L.) as therapeutic agents: a review. Atlantis Press. 2023:96–101.

El Gaafary M, Abdel-Baki PM, El-Halawany AM, et al. Prenylated xanthones from mangosteen (Garcinia mangostana) target oxidative mitochondrial respiration in cancer cells. Biomed Pharmacother. 2024;179:117365.

Kumar V, Singh P, Tripathi DN. α-Mangostin mediated pharmacological modulation of hepatic carbohydrate metabolism in diabetes-induced Wistar rats. Beni-Suef Univ J Basic Appl Sci. 2021;10:10.

Chakraborty S, Kashyap A, Dutta H. Mangosteen. In: Minor Fruits. Apple Academic Press; 2025. p. 143–76.

Eiselt VA, Bereswill S, Heimesaat MM. Recent evidence on prominent anti-bacterial capacities of compounds derived from the mangosteen fruit. Eur J Microbiol Immunol. 2025;15(2):63–73.

Pratiwi YS, Rini DM, Defri I, et al. Utilization of Garcinia mangostana L. peel as an immunomodulator to improve the quality of human resources: a systematic review. Amerta Nutr. 2025;9(2).

Li R, Inbaraj BS, Chen BH. Quantification of xanthone and anthocyanin in mangosteen peel by UPLC-MS/MS and preparation of nanoemulsions for studying their inhibition effects on liver cancer cells. Int J Mol Sci. 2023;24(4):3934.

Hedridani N, Wirjatmadi B, Kuntoro, Wikurendra EA. Effect of mangosteen peel extract on increasing the number of endocrine cells in the pancreas Langerhans islands and decreasing tumor necrosis factor alpha in streptozotocin-induced male rats. J Pharm Negat Results. 2023;14(3):3539–49.

Pang LW, Hamzah S, Tan SL, Mah SH, Yow HY. The effects and mechanisms of xanthones in Alzheimer’s disease: a systematic review. Neurochem Res. 2023;48(12):3485–511.

Majdalawieh AF, Khatib BK, Terro TM. α-Mangostin is a xanthone derivative from mangosteen with potent immunomodulatory and anti-inflammatory properties. Biomolecules. 2025;15(5):681.

Zhang Q, Wang L, Li H, et al. Gartanin as an isoprenylated xanthone from mangosteen (Garcinia mangostana L.): insights into its synthesis, extraction, determination, and bioactivity. Food Rev Int. 2025;41(1):218–35.

Majdalawieh AF, Terro TM, Ahari SH, Abu-Yousef IA. α-Mangostin: a xanthone derivative in mangosteen with potent anti-cancer properties. Biomolecules. 2024;14(11):1382.

Thew HY, Tan YC, Ong YS, Goh BH, Khaw KY. A systematic review of neuroprotective effects of mangosteen and its xanthones against oxidative stress and inflammation. Planta Med. 2025 Aug 22.

Safaei R, Sakhaee K, Saberifar M, et al. Mechanistic insights into the xanthones present in mangosteen fruit (Garcinia mangostana) and their applications in diabetes and related complications. J Food Biochem. 2023;2023(1):5334312.

Yahyazadeh R, Rahimi VB, Yahyazadeh A, Askari VR. A mechanistic review on the protective effects of mangosteen and its xanthones against hazardous materials and toxins. Curr Neuropharmacol. 2024;22(12):1986–2015.

Downloads

Published

2026-04-09

How to Cite

Purwoko, Y., Nugroho, K. H. ., Setiati, S., & Rachmawati, B. (2026). Effects of Garcinia mangostana Peel Extract on Glycemic Control in Type 2 Diabetes Mellitus: A Systematic Review of Human Studies: A Systematic Review of Human Studies. Acta Medica Indonesiana, 58(1), 52. Retrieved from https://actamedindones.org/index.php/ijim/article/view/3273

Most read articles by the same author(s)

1 2 3 4 5 > >>